These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11171923)

  • 1. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
    Chamberlain MC
    Neurology; 2001 Feb; 56(3):425-6. PubMed ID: 11171923
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of leptomeningeal metastases from breast cancer to hormonal therapy.
    Boogerd W; Dorresteijn LD; van Der Sande JJ; de Gast GC; Bruning PF
    Neurology; 2000 Jul; 55(1):117-9. PubMed ID: 10891918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine Therapy for Leptomeningeal Metastases from ER-Positive Breast Cancer: Case Report and a Review of the Literature.
    Zoghi B; Elledge R
    Breast J; 2016; 22(2):218-23. PubMed ID: 26748605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable clinical benefit with exemestane in leptomeningeal metastasis of breast cancer.
    Navarro Martín LM; Ocaña Fernández A; Rodríguez Sánchez CA; Ruiz Martín I; Cruz Hernández JJ
    Clin Transl Oncol; 2005 Sep; 7(8):358-60. PubMed ID: 16185606
    [No Abstract]   [Full Text] [Related]  

  • 5. Dural metastases in prostate cancer.
    Bentley AM; Keen JC
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):165-6. PubMed ID: 12801058
    [No Abstract]   [Full Text] [Related]  

  • 6. Sanctuary site leptomeningeal metastases in HER-2 positive breast cancer: A review in the era of trastuzumab.
    Kordbacheh T; Law WY; Smith IE
    Breast; 2016 Apr; 26():54-8. PubMed ID: 27017242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.
    Rogers LR; Remer SE; Tejwani S
    Neuro Oncol; 2004 Jan; 6(1):63-4. PubMed ID: 14769142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.
    Ricciardi GRR; Russo A; Franchina T; Schifano S; Mastroeni G; Santacaterina A; Adamo V
    BMC Cancer; 2018 Jan; 18(1):97. PubMed ID: 29370839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine therapy of central nervous system metastases from breast cancer.
    Ekenel M; Hormigo AM; Peak S; Deangelis LM; Abrey LE
    J Neurooncol; 2007 Nov; 85(2):223-7. PubMed ID: 17611719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
    Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
    Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.
    Santa-Maria CA; Cimino-Mathews A; Moseley KF; Wolff AC; Blakeley JO; Connolly RM
    Clin Breast Cancer; 2012 Dec; 12(6):445-9. PubMed ID: 23010203
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
    Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
    Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.
    Tham YL; Hinckley L; Teh BS; Elledge R
    Clin Breast Cancer; 2006 Jun; 7(2):164-6. PubMed ID: 16800978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy].
    Andrés E; Goichot B; Kurtz JE; Dufour P; Imler M; Schlienger JL
    Presse Med; 1999 Jan; 28(2):75. PubMed ID: 9989298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leptomeningeal carcinomatous metastases].
    Mauro A
    Minerva Med; 1984 May; 75(22-23):1395-9. PubMed ID: 6547214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
    Shigekawa T; Takeuchi H; Misumi M; Matsuura K; Sano H; Fujiuchi N; Okubo K; Osaki A; Aogi K; Saeki T
    Breast Cancer; 2009; 16(1):88-92. PubMed ID: 18478315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management.
    Berg SL; Chamberlain MC
    Cancer Treat Res; 2005; 125():121-46. PubMed ID: 16211887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection.
    Ozdogan M; Samur M; Bozcuk HS; Sagtas E; Yildiz M; Artac M; Savas B
    Jpn J Clin Oncol; 2003 May; 33(5):229-31. PubMed ID: 12865466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.